HUE060972T2 - 2-es típusú sertés cirkovírus (PCV) alegység vakcina - Google Patents

2-es típusú sertés cirkovírus (PCV) alegység vakcina

Info

Publication number: HUE060972T2
Authority: HU; Hungary
Prior art keywords: pcv2; subunit vaccine; porcine circovirus; circovirus type; type
Prior art date: 2013-08-23

Application number

HUE14761742A

Other languages

English (en)

Inventor

Gregory Haiwick

Original Assignee

Boehringer Ingelheim Animal Health Usa Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-08-23

Filing date

2014-08-20

Publication date

2023-05-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51494509&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE060972(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2014-08-20 Application filed by Boehringer Ingelheim Animal Health Usa Inc filed Critical Boehringer Ingelheim Animal Health Usa Inc

2023-05-28 Publication of HUE060972T2 publication Critical patent/HUE060972T2/hu

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14041—Use of virus, viral particle or viral elements as a vector
- C12N2710/14043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vectore
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Microbiology (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Wood Science & Technology (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Mycology (AREA)
Pharmacology & Pharmacy (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Biomedical Technology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

HUE14761742A 2013-08-23 2014-08-20 2-es típusú sertés cirkovírus (PCV) alegység vakcina HUE060972T2 (hu)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US201361869353P	2013-08-23	2013-08-23

Publications (1)

Publication Number	Publication Date
HUE060972T2 true HUE060972T2 (hu)	2023-05-28

Family

ID=51494509

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HUE14761742A HUE060972T2 (hu)	2013-08-23	2014-08-20	2-es típusú sertés cirkovírus (PCV) alegység vakcina

Country Status (7)

Country	Link
US (2)	US20150056248A1 (hu)
EP (2)	EP4176899A1 (hu)
CN (1)	CN105451765A (hu)
DK (1)	DK3035958T3 (hu)
ES (1)	ES2932410T3 (hu)
HU (1)	HUE060972T2 (hu)
WO (1)	WO2015026912A1 (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA95602C2 (ru)	2004-12-30	2011-08-25	Берингер Ингельхейм Ветмедика, Инк.	Иммуногенная композиция цвс2 и способы приготовления такой композиции
RU2488407C2 (ru)	2005-12-29	2013-07-27	Берингер Ингельхайм Ветмедика, Инк.	Поливалентные иммуногенные композиции pcv2 и способы получения таких композиций
WO2007094893A2 (en)	2005-12-29	2007-08-23	Boehringer Ingelheim Vetmedica, Inc.	Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs
US20100129397A1 (en)	2006-12-11	2010-05-27	Boehringer Ingelheim Vetmedica, Inc.	Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
EP1941903A1 (en)	2007-01-03	2008-07-09	Boehringer Ingelheim Vetmedica Gmbh	Prophylaxis and treatment of PRDC
EP1958644A1 (en)	2007-02-13	2008-08-20	Boehringer Ingelheim Vetmedica Gmbh	Prevention and treatment of sub-clinical pcvd
CA2712006A1 (en)	2008-01-23	2009-10-15	Boehringer Ingelheim Vetmedica, Inc.	Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions
ES2932410T3 (es)	2013-08-23	2023-01-18	Boehringer Ingelheim Animal Health Usa Inc	Vacuna de subunidad de circovirus porcino tipo 2 (PCV2)
US9987348B2 (en) *	2013-09-25	2018-06-05	Zoetis Services Llc	PCV2B divergent vaccine composition and methods of use
CN107056897B (zh) *	2017-01-22	2020-08-25	中牧实业股份有限公司	猪圆环合成肽疫苗及其制备方法和应用
BR112020002006A2 (pt)	2017-08-03	2020-08-11	Intervet International B.V.	vacina compreendendo uma proteína orf2 de pcv2 de genótipo 2b
CN113831414B (zh) *	2020-06-24	2023-08-01	上海中鹰科技实业有限公司	猪圆环病毒2b型Capsid-Fc融合蛋白及其制备方法、基因及构建方法和应用
CN112316131A (zh) *	2020-12-31	2021-02-05	北京科牧丰生物制药有限公司	一种pcv2型杆状病毒、猪肺炎支原体二联灭活疫苗及制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2909462A (en)	1955-12-08	1959-10-20	Bristol Myers Co	Acrylic acid polymer laxative compositions
PL2460820T3 (pl) *	2004-12-30	2019-09-30	Boehringer Ingelheim Animal Health USA Inc.	Immunogenne kompozycje PCV2 stosowane w zapobieganiu infekcjom PCV2
US7833707B2 (en) *	2004-12-30	2010-11-16	Boehringer Ingelheim Vetmedica, Inc.	Methods of overexpression and recovery of porcine circovirus type 2 ORF2
PL2094872T5 (pl)	2006-12-15	2020-10-05	Boehringer Ingelheim Animal Health USA Inc.	Leczenie świń seropozytywnych wobec przeciwciała anty-pcv2 antygenem pcv2
EP1941903A1 (en) *	2007-01-03	2008-07-09	Boehringer Ingelheim Vetmedica Gmbh	Prophylaxis and treatment of PRDC
US20090017064A1 (en) *	2007-07-10	2009-01-15	Wyeth	Methods and Compositions for Immunizing Pigs Against Porcine Circovirus
RU2493254C9 (ru)	2007-12-21	2013-12-20	ВАЙЕТ ЭлЭлСи	Способы и композиции для иммунизации свиней против свиного цирковируса
PT2547770T (pt) *	2010-03-16	2020-03-04	Virginia Tech Intellectual Properties Inc	Vacina contra circovirus suíno, quimérica, atenuada, viva
TWI442935B (zh)	2010-12-22	2014-07-01	Sbc Virbac Ltd	豬第二型環狀病毒（ＰｏｒｃｉｎｅＣｉｒｃｏｖｉｒｕｓＴｙｐｅ２）、含彼之免疫組合物、檢測套組及其應用
CN102296089B (zh) *	2011-04-20	2013-09-11	中国兽医药品监察所	高效制备猪圆环病毒2型空衣壳粒子的方法
CN103122352B (zh) *	2012-09-27	2015-02-11	华中农业大学	一种猪圆环病毒2型重组杆状病毒及制备方法和应用
ES2932410T3 (es)	2013-08-23	2023-01-18	Boehringer Ingelheim Animal Health Usa Inc	Vacuna de subunidad de circovirus porcino tipo 2 (PCV2)

2014
- 2014-08-20 ES ES14761742T patent/ES2932410T3/es active Active
- 2014-08-20 WO PCT/US2014/051839 patent/WO2015026912A1/en active Application Filing
- 2014-08-20 CN CN201480045584.2A patent/CN105451765A/zh active Pending
- 2014-08-20 EP EP22202459.8A patent/EP4176899A1/en active Pending
- 2014-08-20 HU HUE14761742A patent/HUE060972T2/hu unknown
- 2014-08-20 US US14/464,132 patent/US20150056248A1/en not_active Abandoned
- 2014-08-20 DK DK14761742.7T patent/DK3035958T3/da active
- 2014-08-20 EP EP14761742.7A patent/EP3035958B1/en active Active
2017
- 2017-04-27 US US15/499,138 patent/US20170232094A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20170232094A1 (en)	2017-08-17
DK3035958T3 (en)	2022-12-12
EP4176899A1 (en)	2023-05-10
WO2015026912A1 (en)	2015-02-26
CN105451765A (zh)	2016-03-30
US20150056248A1 (en)	2015-02-26
ES2932410T3 (es)	2023-01-18
EP3035958B1 (en)	2022-10-26
EP3035958A1 (en)	2016-06-29

Publication	Publication Date	Title
HUE060972T2 (hu)	2023-05-28	2-es típusú sertés cirkovírus (PCV) alegység vakcina
IL276210A (en)	2020-09-30	MERS-COV vaccine
IL279395A (en)	2021-01-31	A vaccine
IL246025B (en)	2022-02-01	Formulations for neoplasia compounds
DK2955192T3 (en)	2020-08-17	Anti-mycoplasma spp. subunit vaccine
IL248223A0 (en)	2016-11-30	Compositions of vaccine
DK2994162T3 (en)	2021-06-21	Vaccine for pcv2 og mycoplasma
HK1224228A1 (zh)	2017-08-18	新型製劑
IL243778A0 (en)	2016-04-21	Combined immune complexes
SG11201506882YA (en)	2015-09-29	Ophthalmic formulations
HK1217206A1 (zh)	2016-12-30	疫苗
DK3076996T3 (en)	2020-03-09	Vaccine mod porcint circovirus type 2
HUE043142T2 (hu)	2019-08-28	Egybeépített implantátum
PL3013363T3 (pl)	2021-04-06	Szczepionka przeciwko dyzenterii świń
GB201301119D0 (en)	2013-03-06	Viral vaccines
SI2815740T1 (sl)	2016-07-29	Oftalmični sestavek
GB201313990D0 (en)	2013-09-18	Combination immunogenic compositions
GB201417258D0 (en)	2014-11-12	Digital applanation tonometer
GB201411371D0 (en)	2014-08-13	Immunogenic composition
GB201411306D0 (en)	2014-08-06	Immunogenic composition
GB201320646D0 (en)	2014-01-08	Vaccine
GB201315556D0 (en)	2013-10-16	Vaccine
GB201405857D0 (en)	2014-05-14	Immunogenic formulations
GB201401883D0 (en)	2014-03-19	Combination immunogenic compositions
GB201314258D0 (en)	2013-09-25	Glycidol preparation